{
  "articles": [
    {
      "path": "contact.html",
      "author": [],
      "contents": "\r\nConnect with me on Twitter, GitHub, and Linkedin.\r\nI am happy to answer gtsummary questions, but please do not email me with questions.\r\nIt is best for the community if questions are asked and answered on a public forum.\r\nQuestions? Post to stackoverflow.com, use the gtsummary tag, and I will be notified of your post.\r\nBug Reports? File a GitHub Issue\r\n\r\n\r\n\r\n\r\nMemorial Sloan Kettering Cancer Center\r\n1275 York Ave.\r\nNew York, NY 10065sjobergd@mskcc.org\r\n\r\n\r\n\r\n\r\n\r\nColumbia University\r\nMailman School of Public Health\r\nDepartment of Biostatistics\r\n722 West 168th St., 6th floor\r\nNew York, NY 10032dds2149@cumc.columbia.edu\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-11-04T15:26:42-04:00"
    },
    {
      "path": "index.html",
      "title": "Daniel D. Sjoberg",
      "author": [],
      "contents": "\r\n\r\nd-article {\r\n  padding-top: 5px;\r\n  border-top: 0px;\r\n}\r\n\r\nd-title h1 {\r\n  text-align: center;\r\n  font-family: Roboto Mono;\r\n  letter-spacing: 3px;\r\n}\r\n\r\nd-title p {\r\n  text-align: center;\r\n}\r\n\r\n.about p {\r\n  text-align: justify;\r\n}\r\n\r\n.hero-left img {\r\n  width: 100%;\r\n  border-radius: 15%;\r\n  border: 3px solid grey;\r\n  display: block;\r\n  margin-left: auto;\r\n  margin-right: auto;\r\n  margin-bottom: 1em;\r\n}\r\n\r\n.hero-right p {\r\n  margin: 10px 0px 10px 0px;\r\n  font-size: 1.2em;\r\n  font-family: Roboto Slab;\r\n}\r\n\r\n.hero-right li {\r\n  margin-bottom: 5px;\r\n  padding-left: 10px;\r\n}\r\n\r\n@media (min-width: 1200px) {\r\n  .hero-left {\r\n    width:32%;\r\n    float:left;\r\n  }\r\n  .hero-right {\r\n    width:63%;\r\n    float:right;\r\n  }\r\n}\r\n\r\n@media (max-width: 1199px) {\r\n  .hero-left img {\r\n    width: 50%;\r\n  }\r\n}\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nEducation\r\n\r\n\r\nDrPH Candidate Columbia University, Biostatistics\r\n\r\n\r\nMA Boston University, Biostatistics\r\n\r\n\r\nBS University of Utah, Mathematics\r\n\r\n\r\n\r\nWork\r\n\r\n\r\nMemorial Sloan Kettering Cancer Center\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\nabout\r\n\r\n\r\nI am a Senior Biostatistician at\r\nMemorial Sloan\r\nKettering Cancer Center in New York City. I am also a DrPH candidate\r\nin Biostatistics\r\nat\r\nColumbia University. My research interests include adaptive methods\r\nin clinical trials, precision medicine, predictive modeling, and\r\nprostate cancer screening methods. In my time away from work and school,\r\nI enjoy baking, going to the beach, running, and programing in R.\r\n\r\n\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-11-04T15:29:27-04:00"
    },
    {
      "path": "publications.html",
      "author": [],
      "contents": "\r\nFor the most up to date list of publications, check out my\r\nGoogle\r\nScholar page.\r\nPeer-reviewed Publications\r\n\r\n\r\nDD Sjoberg, K Whiting, M Curry, JA Lavery, J Larmarange\r\n(2021). “Reproducible Summary Tables with the gtsummary Package..” R\r\nJournal, 13 (1)\r\n\r\nDD Sjoberg, AJ Vickers, M Assel, A Dahlin, BY Poon, D\r\nUlmert, H Lilja (2018). “Twenty-year risk of prostate cancer death by\r\nmidlife prostate-specific antigen and a panel of four kallikrein markers\r\nin a large population-based cohort of healthy men.” European\r\nurology, 73 (6), 941-948\r\n\r\nDD Sjoberg (2014). “Toward a smarter prostate cancer\r\nscreening program..” European Urology, 68 (4), 598-599\r\n\r\nMA Preston, JL Batista, KM Wilson, SV Carlsson, T Gerke, DD\r\nSjoberg, and others (2016). “Baseline prostate-specific antigen\r\nlevels in midlife predict lethal prostate cancer.” Journal of\r\nClinical Oncology, 34 (23), 2705\r\n\r\nS Punnen, DD Sjoberg, SM Zappala, D Parekh (2015). “A\r\nmulti-institutional prospective trial in the United States to confirm\r\nthe 4Kscore identification of men with high-grade prostate cancer.”\r\nJOURNAL OF CLINICAL ONCOLOGY, 33 (7)\r\n\r\nBH Bochner, DD Sjoberg, VP Laudone (2014). “A\r\nrandomized trial of robot-assisted laparoscopic radical cystectomy.”\r\nNew England journal of medicine, 371 (4), 389-390\r\n\r\nB Ehdaie, CM Tempany, F Holland, DD Sjoberg, AS Kibel,\r\nQD Trinh, and others (2022). “MRI-guided focused ultrasound focal\r\ntherapy for patients with intermediate-risk prostate cancer: a phase 2b,\r\nmulticentre study.” The Lancet Oncology, 23 (7),\r\n910-918\r\n\r\nN Almassi, EA Vertosick, DD Sjoberg, NC Wong, C Huang,\r\nEJ Pietzak, and others (2022). “Pathological and oncological outcomes in\r\npatients with sarcomatoid differentiation undergoing cystectomy.”\r\nBJU international, 129 (4), 463-469\r\n\r\nGA Jibara, M Perera, EA Vertosick, DD Sjoberg, A\r\nVickers, PT Scardino, and others (2022). “Association of family history\r\nof cancer with clinical and pathological outcomes for prostate cancer\r\npatients on active surveillance.” The Journal of Urology,\r\n10.1097/JU. 0000000000002668\r\n\r\nS Dason, EA Vertosick, K Udo, DD Sjoberg, AJ Vickers, H\r\nAl‐Ahmadie, and others (2022). “Clinical utility of subclassifying\r\npositive surgical margins at radical prostatectomy.” BJU\r\ninternational, 129 (2), 194-200\r\n\r\nH Truong, K Breen, S Nandakumar, DD Sjoberg, Y Kemel, N\r\nMehta, and others (2022). “Gene-based Confirmatory Germline Testing\r\nFollowing Tumor-only Sequencing of Prostate Cancer.” European\r\nUrology, \r\n\r\nCA Bravi, P Dell’Oglio, E Mazzone, MC Moschovas, U Falagario, P Piazza,\r\nDD Sjoberg, and others (2022). “The surgical learning\r\ncurve for biochemical recurrence after robot-assisted radical\r\nprostatectomy.” European Urology Oncology, \r\n\r\nKM Kan, AL Tin, GL Stearns, JA Eastham, DD Sjoberg, JS\r\nSandhu (2022). “De Novo Urinary Storage Symptoms Are Common after\r\nRadical Prostatectomy: Incidence, Natural History and Predictors.”\r\nThe Journal of Urology, 207 (3), 601-608\r\n\r\nA Larcher, F Belladelli, U Capitanio, F Montorsi (2022). “Long-distance\r\nRobot-assisted Teleoperation: Every Millisecond Counts.” European\r\nurology, S, S0302-2838 (22) 02709-9\r\n\r\nAJ Vickers, DD Sjoberg (2022). “Methods Modernizing\r\nStatistical Reporting in Medical Journals: Challenges and Future\r\nDirections..” European Urology, S, S0302-2838 (22)\r\n02643\r\n\r\nAW Silagy, AL Tin, P Rappold, EA Vertosick, R Mano, K Attalla, A Yoo,\r\nDD Sjoberg, and others (2022). “Systemic immunological\r\ndeterminants of oncological outcomes after surgery for localized renal\r\ncell carcinoma.” Clinical Genitourinary Cancer, 20 (5),\r\ne432-e439\r\n\r\nF Pellegrino, DD Sjoberg, AL Tin, NE Benfante, A\r\nBriganti, F Montorsi, and others (2022). “Relationship Between Age,\r\nComorbidity, and the Prevalence of Erectile Dysfunction.” European\r\nUrology Focus, \r\n\r\nC Huang, M Assel, BB Beech, NE Benfante, DD Sjoberg, A\r\nTouijer, and others (2022). “Uretero‐enteric stricture outcomes:\r\nsecondary analysis of a randomised controlled trial comparing open\r\nversus robot‐assisted radical cystectomy.” BJU international,\r\n\r\n\r\nM Perera, A Vilaseca, AL Tin, DP Nguyen, RB Corradi, AS Touijer,\r\nDD Sjoberg, and others (2022). “Morbidity of salvage\r\nradical prostatectomy: limited impact of the minimally invasive\r\napproach.” World Journal of Urology, 1-8\r\n\r\nD Bock, M Nyberg, A Lantz, SV Carlsson, DD Sjoberg, S\r\nCarlsson, and others (2022). “Learning curve for robot-assisted\r\nlaparoscopic radical prostatectomy in a large prospective multicentre\r\nstudy.” Scandinavian Journal of Urology, 1-9\r\n\r\nO Ettala, I Jambor, IM Perez, M Seppänen, A Kaipia, H Seikkula,\r\nDD Sjoberg, and others (2022). “Individualised\r\nnon-contrast MRI-based risk estimation and shared decision-making in men\r\nwith a suspicion of prostate cancer: protocol for multicentre randomised\r\ncontrolled ….” BMJ open, 12 (4), e053118\r\n\r\nKA Touijer, DD Sjoberg, N Benfante, VP Laudone, B\r\nEhdaie, JA Eastham, and others (2021). “Limited versus extended pelvic\r\nlymph node dissection for prostate cancer: a randomized clinical trial.”\r\nEuropean Urology Oncology, 4 (4), 532-539\r\n\r\nM Nyberg, DD Sjoberg, SV Carlsson, U Wilderäng, S\r\nCarlsson, J Stranne, and others (2021). “Surgeon heterogeneity\r\nsignificantly affects functional and oncological outcomes after radical\r\nprostatectomy in the Swedish LAPPRO trial.” Bju International, 127\r\n(3), 361-368\r\n\r\nCR Tracy, KJ Flynn, DD Sjoberg, PT Gellhaus, CM Metz, B\r\nEhdaie (2021). “Optimizing MRI-targeted prostate biopsy: the diagnostic\r\nbenefit of additional targeted biopsy cores.” Urologic Oncology:\r\nSeminars and Original Investigations, 39 (3), 193. e1-193.\r\ne6\r\n\r\nT Stonier, AL Tin, DD Sjoberg, G Jibara, AJ Vickers, S\r\nFine, J Eastham (2021). “Selecting patients with favorable risk, grade\r\ngroup 2 prostate cancer for active surveillance—does magnetic resonance\r\nimaging have a role?.” The Journal of urology, 205 (4),\r\n1063-1068\r\n\r\nGT Chesnut, AL Tin, DD Sjoberg, B Jang, N Benfante, S\r\nSarraf, H Herr, and others (2021). “Electronic rapid fitness assessment\r\nidentifies factors associated with adverse early postoperative outcomes\r\nfollowing radical cystectomy.” The Journal of urology, 205 (2),\r\n400-406\r\n\r\nB Ehdaie, G Jibara, DD Sjoberg, V Laudone, J Eastham, K\r\nTouijer, and others (2021). “The duration of antibiotics prophylaxis at\r\nthe time of catheter removal after radical prostatectomy: clinically\r\nintegrated, cluster, randomized trial.” The Journal of Urology, 206\r\n(3), 662-668\r\n\r\nCA Bravi, G Rosiello, G Fallara, E Vertosick, A Tin, DD\r\nSjoberg, M Bianchi, and others (2021). “Predictive value of\r\npreoperative neutrophil-to-lymphocyte ratio in localized prostate\r\ncancer: results from a surgical series at a high-volume institution.”\r\nMinerva urology and nephrology, 73 (4), 481\r\n\r\nRG Alvim, AL Tin, L Nogueira, NC Wong, RC Fonseca, DD\r\nSjoberg, and others (2021). “Functional and Oncological\r\nOutcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in\r\nRisk-Adapted Management.” Urology, 157, 174-180\r\n\r\nH Herr, EA Vertosick, G Dalbagni, EK Cha, R Smith, N Benfante,\r\nDD Sjoberg, and others (2021). “Prospective Phase II\r\nStudy to Evaluate Response to Two Induction Courses (12 intravesical\r\ninstillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder\r\nCancer.” Urology, 157, 197-200\r\n\r\nG Jibara, DD Sjoberg, GL Stearns, Y Stabholz, A\r\nFathollahi, LS Leddy, and others (2021). “Photoselective Vaporization of\r\nthe Prostate in the Management of Lower Urinary Tract Symptoms in\r\nProstate Cancer Patients on Active Surveillance.” Urology, 156,\r\n225-230\r\n\r\nJ Coleman, DD Sjoberg, Q Demac, C Odea, M McGill, A\r\nTracey, L Nogueira, and others (2021). “Results of the PCM-204 phase 2b\r\ntrial of partial-gland ablation for men with intermediate-risk prostate\r\ncancer with padeliporfin (WST11 or TOOKAD) vascular-targeted ….”\r\nJournal of Urology, e, e814-e815\r\n\r\nGL Stearns, AL Tin, NE Benfante, DD Sjoberg, JS Sandhu\r\n(2021). “Outcomes of Ureteroneocystostomy in Patients With Cancer.”\r\nUrology, 158, 131-134\r\n\r\nGT Chesnut, AL Tin, KA Fleshner, NE Benfante, AJ Vickers, JA Eastham,\r\nDD Sjoberg, and others (2021). “Estimating patient\r\nhealth in prostate cancer treatment counseling.” Prostate cancer and\r\nprostatic diseases, 1-5\r\n\r\nCA BRAVI, G ROSIELLO, G FALLARA, E VERTOSICK, A TIN, DD\r\nSjoberg, and others (2021). “Minerva Urology and Nephrology\r\n2021 August; 73 (4): 481-8.” Minerva, 73\r\n\r\nGT Chesnut, AL Tin, A Sivaraman, T Takeda, T Lee, J Fainberg, DD\r\nSjoberg, and others (2021). “Defining the index lesion for\r\npotential salvage partial or hemi-gland ablation after radiation therapy\r\nfor localized prostate cancer.” Urologic Oncology: Seminars and\r\nOriginal Investigations, 39 (8), 495. e17-495 …\r\n\r\nPE Lonergan, EA Vertosick, M Assel, DD Sjoberg, A\r\nHaese, M Graefen, and others (2021). “Prospective validation of\r\nmicroseminoprotein‐β added to the 4Kscore in predicting high‐grade\r\nprostate cancer in an international multicentre cohort.” BJU\r\ninternational, 128 (2), 218-224\r\n\r\nGT Chesnut, EA Vertosick, N Benfante, DD Sjoberg, J\r\nFainberg, T Lee, and others (2020). “Role of changes in magnetic\r\nresonance imaging or clinical stage in evaluation of disease progression\r\nfor men with prostate cancer on active surveillance.” European\r\nurology, 77 (4), 501-507\r\n\r\nS Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers,\r\nVE Reuter, and others (2020). “Long-term outcomes of active surveillance\r\nfor prostate cancer: the Memorial Sloan Kettering Cancer Center\r\nexperience.” The Journal of urology, 203 (6), 1122-1127\r\n\r\nS Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers,\r\nVE Reuter, and others (2020). “Risk of metastasis in men with grade\r\ngroup 2 prostate cancer managed with active surveillance at a tertiary\r\ncancer center.” The Journal of urology, 203 (6),\r\n1117-1121\r\n\r\nKA Amin, EA Vertosick, G Stearns, A Fathollahi, DD\r\nSjoberg, MS Donat, and others (2020). “Predictors of benign\r\nureteroenteric anastomotic strictures after radical cystectomy and\r\nurinary diversion.” Urology, 144, 225-229\r\n\r\nN Almassi, EK Cha, EA Vertosick, C Huang, N Wong, S Dason, DD\r\nSjoberg, and others (2020). “Trends in management and outcomes\r\namong patients with urothelial carcinoma undergoing radical cystectomy\r\nfrom 1995 to 2015: the Memorial Sloan Kettering experience.” The\r\nJournal of urology, 204 (4), 677-684\r\n\r\nAJ Vickers, MJ Assel, DD Sjoberg, R Qin, Z Zhao, T\r\nKoyama, A Botchway, and others (2020). “Guidelines for reporting of\r\nfigures and tables for clinical research in urology.” The Journal of\r\nUrology, 204 (1), 121-133\r\n\r\nEA Vertosick, C Häggström, DD Sjoberg, G Hallmans, R\r\nJohansson, and others (2020). “Prespecified 4-Kallikrein marker model at\r\nage 50 or 60 for early detection of lethal prostate cancer in a large\r\npopulation based cohort of asymptomatic men followed for 20 years.”\r\nThe Journal of urology, 204 (2), 281-288\r\n\r\nCA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio,\r\nDD Sjoberg, and others (2020). “Androgen deprivation\r\ntherapy in men with node-positive prostate cancer treated with\r\npostoperative radiotherapy.” Urologic Oncology: Seminars and\r\nOriginal Investigations, 38 (4), 204-209\r\n\r\nR Mano, EA Vertosick, J Sarcona, DD Sjoberg, NE\r\nBenfante, TF Donahue, and others (2020). “Primary urethral cancer:\r\ntreatment patterns and associated outcomes.” BJU international, 126\r\n(3), 359-366\r\n\r\nA Haese, AL Tin, SV Carlsson, DD Sjoberg, D Pehrke, T\r\nSteuber, and others (2020). “A pre-specified model based on four\r\nkallikrein markers in blood improves predictions of adverse pathology\r\nand biochemical recurrence after radical prostatectomy.” British\r\njournal of cancer, 123 (4), 604-609\r\n\r\nA Vilaseca, G Guglielmetti, EA Vertosick, DD Sjoberg, A\r\nGrasso, and others (2020). “Value of partial nephrectomy for renal\r\ncortical tumors of cT2 or greater stage: a risk-benefit analysis of\r\nrenal function preservation versus increased postoperative morbidity.”\r\nEuropean urology oncology, 3 (3), 365-371\r\n\r\nJC Hu, B Ehdaie, J Sandhu, DD Sjoberg, SV Carlsson, M\r\nTzeng, and others (2020). “Asian-American race and urinary continence\r\nafter radical prostatectomy.” European Urology Open Science, 22,\r\n51\r\n\r\nGT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson,\r\nT Lee, and others (2020). “Patient-reported pain, discomfort, and\r\nanxiety during magnetic resonance imaging-targeted prostate biopsy.”\r\nCanadian Urological Association Journal, 14 (5), E202\r\n\r\nW Li, M Bicak, DD Sjoberg, E Vertosick, A Dahlin, O\r\nMelander, D Ulmert, and others (2020). “Genome‐wide association study\r\nidentifies novel single nucleotide polymorphisms having age‐specific\r\neffect on prostate‐specific antigen levels.” The Prostate, 80 (16),\r\n1405-1412\r\n\r\nS Dason, EK Cha, C Falavolti, EA Vertosick, LW Dean, VA McPherson,\r\nDD Sjoberg, and others (2020). “Late recurrences\r\nfollowing radical cystectomy have distinct prognostic and management\r\nconsiderations.” The Journal of urology, 204 (3),\r\n460-465\r\n\r\nGT Chesnut, N Benfante, D Barham, LW Dean, A Tin, DD\r\nSjoberg, and others (2020). “Routine Postoperative Hemoglobin\r\nAssessment Poorly Predicts Transfusion Requirement among Patients\r\nUndergoing Minimally Invasive Radical Prostatectomy.” Urology\r\npractice, 7 (4), 299-304\r\n\r\nS Erestam, D Bock, A Erichsen Andersson, A Bjartell, S Carlsson,\r\nDD Sjoberg, and others (2020). “Associations between\r\nintraoperative factors and surgeons’ self-assessed operative\r\nsatisfaction.” Surgical endoscopy, 34 (1), 61-68\r\n\r\nCA Bravi, A Tin, E Vertosick, E Mazzone, M Bandini, P Dell’Oglio,\r\nDD Sjoberg, and others (2020). “Relative contribution\r\nof androgen deprivation therapy in combination with adjuvant\r\nradiotherapy for node-positive prostate cancer..” Urologic oncology,\r\n38 (4), 204\r\n\r\nT Takeda, AL Tin, RB Corradi, R Alvim, T Hashimoto, Y Ito, DP Nguyen,\r\nDD Sjoberg, and others (2020). “Extensive disease among\r\npotential candidates for hemi‐ablative focal therapy for prostate\r\ncancer.” International Journal of Urology, 27 (2),\r\n179-185\r\n\r\nT Stonier, AL Tin, DD Sjoberg, G Jibara, AJ Vickers, S\r\nFine, J Eastham (2020). “Selecting Patients with Favorable Risk, Grade\r\nGroup 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance\r\nImaging Have a Role?.” The Journal of Urology, 205 (4),\r\n1063-1068\r\n\r\nKA Touijer, DD Sjoberg, N Benfante, NP Brau, IR\r\nBelenchón, CM Barrull, and others (2020). “Comparison of erectile\r\nfunction recovery between limited and extended pelvic lymph node\r\ndissection for prostate cancer: Results from a large,\r\nclinically-integrated, randomized ….” European Urology Open Science,\r\n19, e2124\r\n\r\nM Assel, DD Sjoberg, A Elders, X Wang, D Huo, A\r\nBotchway, K Delfino, and others (2019). “Guidelines for reporting of\r\nstatistics for clinical research in urology.” BJU international, 123\r\n(3), 401-410\r\n\r\nCA Bravi, E Vertosick, N Benfante, A Tin, DD Sjoberg,\r\nAA Hakimi, K Touijer, and others (2019). “Impact of acute kidney injury\r\nand its duration on long-term renal function after partial nephrectomy.”\r\nEuropean urology, 76 (3), 398-403\r\n\r\nMA Preston, T Gerke, SV Carlsson, L Signorello, DD\r\nSjoberg, SC Markt, and others (2019). “Baseline\r\nprostate-specific antigen level in midlife and aggressive prostate\r\ncancer in black men.” European urology, 75 (3), 399-407\r\n\r\nLW Dean, M Assel, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, YB Chen, and others (2019). “Clinical usefulness of total\r\nlength of Gleason pattern 4 on biopsy in men with grade group 2 prostate\r\ncancer.” The Journal of urology, 201 (1), 77-83\r\n\r\nX Wu, H Scott, SV Carlsson, DD Sjoberg, L Cerundolo, H\r\nLilja, R Prevo, and others (2019). “Increased EZH2 expression in\r\nprostate cancer is associated with metastatic recurrence following\r\nexternal beam radiotherapy.” The Prostate, 79 (10),\r\n1079-1089\r\n\r\nY Ito, K Udo, EA Vertosick, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, and others (2019). “Clinical usefulness of prostate and\r\ntumor volume related parameters following radical prostatectomy for\r\nlocalized prostate cancer.” The Journal of urology, 201 (3),\r\n535-540\r\n\r\nP Capogrosso, EA Vertosick, NE Benfante, DD Sjoberg, AJ\r\nVickers, and others (2019). “Can we improve the preoperative prediction\r\nof prostate cancer recurrence with multiparametric MRI?.” Clinical\r\ngenitourinary cancer, 17 (4), e745-e750\r\n\r\nNC Wong, RG Alvim, DD Sjoberg, R Shingarev, NE Power, M\r\nSpaliviero, and others (2019). “Phase III trial of intravenous mannitol\r\nversus placebo during nephron-sparing surgery: Post hoc analysis of 3-yr\r\noutcomes.” European urology focus, 5 (6), 977-979\r\n\r\nY Ito, EA Vertosick, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, YB Chen, and others (2019). “In organ-confined prostate\r\ncancer, tumor quantitation not found to aid in prediction of biochemical\r\nrecurrence.” The American journal of surgical pathology, 43 (8),\r\n1061\r\n\r\nGT Chesnut, P Zareba, DD Sjoberg, M Mamoor, S Carlsson,\r\nT Lee (2019). “Patient experience of MRI-targeted prostate biopsy\r\nPatient-reported pain, discomfort, and anxiety during magnetic resonance\r\nimaging-targeted prostate biopsy.” Can Urol Assoc J, 29\r\n\r\nM Assel, DD Sjoberg, JWF Catto, AJ Vickers (2019).\r\n“Innovations in statistical review at European Urology.” European\r\nurology, 75 (1), 1\r\n\r\nHL Bernie, B Nascimento, D Katz, A Tin, N Benfante, DD\r\nSjoberg, and others (2019). “160 Predictors of Worsening\r\nErectile Function in Men With Functional Erections Early After Radical\r\nProstatectomy.” The Journal of Sexual Medicine, 16 (4),\r\nS81\r\n\r\nB Nascimento, HL Bernie, H Taniguchi, EP Miranda, J Terrier, S Carlsson,\r\nDD Sjoberg, and others (2019). “276 Baseline\r\nCharacteristics of Treated and Untreated Patients with Peyronie’s\r\nDisease (PD).” The Journal of Sexual Medicine, 16 (4),\r\nS132\r\n\r\nS Fine, Y Ito, E Vertosick, DD Sjoberg, A Vickers, H\r\nAl-Ahmadie, YB Chen, and others (2019). “In Organ-Confined Prostate\r\nCancer at Radical Prostatectomy, neither Total Tumor Volume nor Maximum\r\nTumor Diameter of the Index Lesion Aids in Prediction of Biochemical\r\nRecurrence.” LABORATORY INVESTIGATION, 99\r\n\r\nBH Bochner, G Dalbagni, KH Marzouk, DD Sjoberg, J Lee,\r\nSM Donat, and others (2018). “Randomized trial comparing open radical\r\ncystectomy and robot-assisted laparoscopic radical cystectomy: oncologic\r\noutcomes.” European urology, 74 (4), 465-471\r\n\r\nKA Touijer, RJ Karnes, N Passoni, DD Sjoberg, M Assel,\r\nN Fossati, and others (2018). “Survival outcomes of men with lymph\r\nnode-positive prostate cancer after radical prostatectomy: a comparative\r\nanalysis of different postoperative management strategies.” European\r\nurology, 73 (6), 890-896\r\n\r\nM Nyberg, J Hugosson, P Wiklund, DD Sjoberg, U\r\nWilderäng, SV Carlsson, and others (2018). “Functional and oncologic\r\noutcomes between open and robotic radical prostatectomy at 24-month\r\nfollow-up in the Swedish LAPPRO trial.” European urology oncology, 1\r\n(5), 353-360\r\n\r\nM Spaliviero, NE Power, KS Murray, DD Sjoberg, NE\r\nBenfante, and others (2018). “Intravenous mannitol versus placebo during\r\npartial nephrectomy in patients with normal kidney function: a\r\ndouble-blind, clinically-integrated, randomized trial.” European\r\nurology, 73 (1), 53-59\r\n\r\nW Li, M Middha, M Bicak, DD Sjoberg, E Vertosick, A\r\nDahlin, and others (2018). “Genome-wide scan identifies role for AOX1 in\r\nprostate cancer survival.” European urology, 74 (6),\r\n710-719\r\n\r\nE Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ\r\nStephenson (2018). “Effects of pathological upstaging or upgrading on\r\nmetastasis and cancer‐specific mortality in men with clinical low‐risk\r\nprostate cancer.” BJU international, 122 (6), 1003-1009\r\n\r\nAD Mally, AL Tin, JK Lee, P Satasivam, EK Cha, SM Donat, HW Herr,\r\nDD Sjoberg, and others (2018). “Clinical outcomes of\r\npatients with T1 nested variant of urothelial carcinoma compared to pure\r\nurothelial carcinoma of the bladder.” Clinical genitourinary cancer,\r\n16 (1), e23-e27\r\n\r\nEK Cha, JP Sfakianos, R Sukhu, AM Yee, DD Sjoberg, BH\r\nBochner (2018). “Poor prognosis of bladder cancer patients with occult\r\nlymph node metastases treated with neoadjuvant chemotherapy.” BJU\r\ninternational, 122 (4), 627-632\r\n\r\nT Takeda, AL Tin, RB Corradi, M Mamoor, NE Benfante, DD\r\nSjoberg, and others (2018). “Topography of prostate cancer\r\nrecurrence after radiation therapy: a detailed mapping study of salvage\r\nradical prostatectomy specimens.” European urology, 73 (4),\r\n488-490\r\n\r\nRG Alvim, F Audenet, EA Vertosick, DD Sjoberg, KA\r\nTouijer (2018). “Performance prediction for surgical outcomes in partial\r\nnephrectomy using nephrometry scores: a comparison of Arterial Based\r\nComplexity (ABC), RENAL, and PADUA systems.” European Urology\r\nOncology, 1 (5), 428-434\r\n\r\nM Rieken, LA Kluth, H Fajkovic, U Capitanio, A Briganti, LM Krabbe,\r\nDD Sjoberg, and others (2018). “Predictors of\r\ncancer-specific survival after disease recurrence in patients with renal\r\ncell carcinoma: the effect of time to recurrence.” Clinical\r\ngenitourinary cancer, 16 (4), e903-e908\r\n\r\nK Marzouk, A Tin, N Liu, DD Sjoberg, AA Hakimi, P\r\nRusso, J Coleman (2018). “The natural history of large renal masses\r\nfollowed on observation.” Urologic Oncology: Seminars and Original\r\nInvestigations, 36 (8), 362. e17-362 …\r\n\r\nAJ Vickers, EA Vertosick, DD Sjoberg (2018). “Value of\r\na statistical model based on four kallikrein markers in blood,\r\ncommercially available as 4Kscore, in all reasonable prostate biopsy\r\nsubgroups.” European urology, 74 (4), 535\r\n\r\nP Capogrosso, A Larcher, DD Sjoberg, EA Vertosick, F\r\nCianflone, and others (2018). “Risk based surveillance after surgical\r\ntreatment of renal cell carcinoma.” The Journal of urology, 200 (1),\r\n61-67\r\n\r\nCM Dowling, M Assel, JE Musser, JJ Meeks, DD Sjoberg, G\r\nBosl, and others (2018). “Clinical outcome of retroperitoneal lymph node\r\ndissection after chemotherapy in patients with pure embryonal carcinoma\r\nin the orchiectomy specimen.” Urology, 114, 133-138\r\n\r\nL Marconi, R de Bruijn, E van Werkhoven, C Beisland, K Fife, DD\r\nSjoberg, and others (2018). “External validation of a\r\npredictive model of survival after cytoreductive nephrectomy for\r\nmetastatic renal cell carcinoma.” World journal of urology, 36 (12),\r\n1973-1980\r\n\r\nA Bagrodia, R Sukhu, AG Winer, E Levy, M Vacchio, B Lee, EJ Pietzak,\r\nDD Sjoberg, and others (2018). “Incidence and effect of\r\nthromboembolic events in radical cystectomy patients undergoing\r\npreoperative chemotherapy for muscle-invasive bladder cancer.”\r\nClinical genitourinary cancer, 16 (1), e113-e120\r\n\r\nA Vickers, EA Vertosick, DD Sjoberg, F Hamdy, D Neal, A\r\nBjartell, and others (2018). “Value of intact prostate specific antigen\r\nand human kallikrein 2 in the 4 kallikrein predictive model: an\r\nindividual patient data meta-analysis.” The Journal of urology, 199\r\n(6), 1470-1474\r\n\r\nJK Lee, DD Sjoberg, MI Miller, AJ Vickers, JP Mulhall,\r\nB Ehdaie (2018). “Improved recovery of erectile function in younger men\r\nafter radical prostatectomy: Does it justify immediate surgery in\r\nlow-risk patients?.” European urology, 73 (1), 33-37\r\n\r\nM Ghanaat, AG Winer, DD Sjoberg, BY Poon, M Kashan, AL\r\nTin, and others (2018). “Comparison of postradical cystectomy ileus\r\nrates using GIA-80 versus GIA-60 intestinal stapler device.”\r\nUrology, 122, 121-126\r\n\r\nK Lapen, L Benusis, S Pearson, B Search, M Coleton, QS Li, DD\r\nSjoberg, and others (2018). “A feasibility study of restorative\r\nyoga versus vigorous yoga intervention for sedentary breast and ovarian\r\ncancer survivors.” International journal of yoga therapy, 28 (1),\r\n79-85\r\n\r\nKS Murray, EA Vertosick, M Spaliviero, JW Mashni Jr, DD\r\nSjoberg, and others (2018). “Importance of wide re‐resection in\r\nadult spermatic cord sarcomas: Report on oncologic outcomes at a single\r\ninstitution.” Journal of surgical oncology, 117 (7),\r\n1464-1468\r\n\r\nF Audenet, EA Vertosick, SW Fine, DD Sjoberg, AJ\r\nVickers, VE Reuter, and others (2018). “Biopsy core features are poor\r\npredictors of adverse pathology in men with grade group 1 prostate\r\ncancer.” The Journal of urology, 199 (4), 961-968\r\n\r\nEJ Pietzak, M Assel, MF Becerra, D Tennenbaum, DR Feldman, DD\r\nSjoberg, and others (2018). “Histologic and oncologic outcomes\r\nfollowing liver mass resection with retroperitoneal lymph node\r\ndissection in patients with nonseminomatous germ cell tumor.”\r\nUrology, 118, 114-118\r\n\r\nDP Nguyen, EA Vertosick, V Sharma, RB Corradi, A Vilaseca, T Takeda,\r\nDD Sjoberg, and others (2018). “Does subclassification\r\nof pathologically organ confined (pT2) prostate cancer provide\r\nprognostic discrimination of outcomes after radical prostatectomy?.”\r\nThe Journal of urology, 199 (6), 1502-1509\r\n\r\nAE Thong, BY Poon, JK Lee, E Vertosick, DD Sjoberg, AJ\r\nVickers, and others (2018). “Concordance between patient-reported and\r\nphysician-reported sexual function after radical prostatectomy.”\r\nUrologic Oncology: Seminars and Original Investigations, 36 (2), 80.\r\ne1-80. e6\r\n\r\nY Ito, K Udo, EA Vertosick, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, and others (2018). “Clinical utility of prostate and tumor\r\nvolume-related parameters following radical prostatectomy for localized\r\nprostate cancer.” The Journal of Urology, \r\n\r\nLW Dean, M Assel, DD Sjoberg, AJ Vickers, HA\r\nAl-Ahmadie, YB Chen, and others (2018). “Clinical utility of total\r\nlength Gleason pattern 4 on biopsy in men with grade group 2 prostate\r\ncancer.” J Urol, 10\r\n\r\nE Kovac, EA Vertosick, DD Sjoberg, AJ Vickers, AJ\r\nStephenson (2018). “Re: Effects of Pathological Upstaging or Upgrading\r\non Metastasis and Cancer-Specific Mortality in Men with Clinical\r\nLow-Risk Prostate Cancer Editorial Comment.” JOURNAL OF UROLOGY, 200\r\n(5), 945-946\r\n\r\nAJ Vickers, H Lilja, Y Dong, DD Sjoberg, PT Scardino\r\n(2018). “Composiciones y métodos para la vigilancia activa del cáncer de\r\npróstata..” , \r\n\r\nY Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja\r\n(2018). “Composiciones y metodos para la vigilancia activa del cancer de\r\nprostata.” , \r\n\r\nH Lilja, PT Scardino, AJ Vickers, Y Dong, DD Sjoberg\r\n(2018). “Sistemas y métodos para la vigilancia activa del cancer de\r\npróstata.” , \r\n\r\nNT John, A Tin, RG Dinatale, NE Benfante, DD Sjoberg,\r\nAA Hakimi, and others (2018). “Genomic Predictors of Response to\r\nNeoadjuvant Cisplatin-based Chemotherapy in Upper Tract Urothelial\r\nCarcinoma (UTUC).” JOURNAL OF UROLOGY, 199 (4),\r\nE216-E216\r\n\r\nNT John, A Tin, DD Sjoberg, N Benfante, AA Hakimi, P\r\nRusso, J Coleman (2018). “Can Imaging Response following Neoadjuvant\r\nChemotherapy in Upper Tract Urothelial Cancer be a Surrogate for\r\nPathologic Response?.” JOURNAL OF UROLOGY, 199 (4),\r\nE214-E215\r\n\r\nSW Fine, H Al-Ahmadie, E Vertosick, DD Sjoberg, A\r\nVickers, YB Chen, and others (2018). “Impact of Zone of Origin in\r\nAnterior-Dominant Prostatic Tumors: Long-Term Biochemical\r\nRecurrence-Free Survival in an Anatomically Well-Annotated Series.”\r\nLABORATORY INVESTIGATION, 98, 340-340\r\n\r\nDW Lin, LF Newcomb, MD Brown, DD Sjoberg, Y Dong, JD\r\nBrooks, and others (2017). “Evaluating the four kallikrein panel of the\r\n4Kscore for prediction of high-grade prostate cancer in men in the\r\nCanary Prostate Active Surveillance Study.” European urology, 72\r\n(3), 448-454\r\n\r\nK Mooney, DL Berry, M Whisenant, DD Sjoberg (2017).\r\n“Improving cancer care through the patient experience: how to use\r\npatient-reported outcomes in clinical practice.” American Society of\r\nClinical Oncology Educational Book, 37, 695-704\r\n\r\nM Assel, DD Sjoberg, AJ Vickers (2017). “The Brier\r\nscore does not evaluate the clinical utility of diagnostic tests or\r\nprediction models.” Diagnostic and prognostic research, 1 (1),\r\n1-7\r\n\r\nMJ O’Shaughnessy, SM McBride, HA Vargas, KA Touijer, MJ Morris,\r\nDD Sjoberg, and others (2017). “A pilot study of a\r\nmultimodal treatment paradigm to accelerate drug evaluations in\r\nearly-stage metastatic prostate cancer.” Urology, 102,\r\n164-172\r\n\r\nR Chen, DD Sjoberg, Y Huang, L Xie, L Zhou, D He, AJ\r\nVickers, Y Sun (2017). “Prostate specific antigen and prostate cancer in\r\nChinese men undergoing initial prostate biopsies compared with Western\r\ncohorts.” The Journal of urology, 197 (1), 90-96\r\n\r\nEH Kim, GL Andriole, ED Crawford, DD Sjoberg, M Assel,\r\nAJ Vickers, and others (2017). “Detection of high grade prostate cancer\r\namong PLCO participants using a prespecified 4-kallikrein marker panel.”\r\nThe Journal of urology, 197 (4), 1041-1047\r\n\r\nBJ Manley, DM Tennenbaum, EA Vertosick, JJ Hsieh, DD\r\nSjoberg, and others (2017). “The difficulty in selecting\r\npatients for cytoreductive nephrectomy: an evaluation of previously\r\ndescribed predictive models.” Urologic Oncology: Seminars and\r\nOriginal Investigations, 35 (1), 35. e1-35. e5\r\n\r\nA Vickers, EA Vertosick, DD Sjoberg, MJ Roobol, F\r\nHamdy, D Neal, and others (2017). “Properties of the 4-kallikrein panel\r\noutside the diagnostic gray zone: meta-analysis of patients with\r\npositive digital rectal examination or prostate specific antigen 10\r\nng/ml ….” The Journal of urology, 197 (3), 607-613\r\n\r\nSM Zappala, Y Dong, V Linder, M Reeve, DD Sjoberg, V\r\nMathur, and others (2017). “The 4Kscore blood test accurately identifies\r\nmen with aggressive prostate cancer prior to prostate biopsy with or\r\nwithout DRE information.” International journal of clinical\r\npractice, 71 (6), e12943\r\n\r\nA Vilaseca, DP Nguyen, EA Vertosick, RB Corradi, M Musquera, M Pérez,\r\nDD Sjoberg, and others (2017). “Obstructive sleep apnea\r\nand Fuhrman grade in patients with clear cell renal cell carcinoma\r\ntreated surgically.” World journal of urology, 35 (1),\r\n51-56\r\n\r\nRB Corradi, EA Vertosick, DP Nguyen, A Vilaseca, DD\r\nSjoberg, and others (2017). “Nephrometry scores and\r\nperioperative outcomes following robotic partial nephrectomy.”\r\nInternational braz j urol, 43, 1075-1083\r\n\r\nS Punnen, B Nahar, NS Prakash, DD Sjoberg, SM Zappala,\r\nDJ Parekh (2017). “The 4Kscore predicts the grade and stage of prostate\r\ncancer in the radical prostatectomy specimen: results from a\r\nmulti-institutional prospective trial.” European urology focus, 3\r\n(1), 94-99\r\n\r\nG Dalbagni, N Benfante, DD Sjoberg, BH Bochner, S\r\nMachele Donat, and others (2017). “Single arm phase I/II study of\r\neverolimus and intravesical gemcitabine in patients with primary or\r\nsecondary carcinoma in situ of the bladder who failed bacillus\r\nCalmette ….” Bladder Cancer, 3 (2), 113-119\r\n\r\nA Polland, EA Vertosick, DD Sjoberg, GL Stearns, LS\r\nLeddy, and others (2017). “Preoperative symptoms predict continence\r\nafter post-radiation transurethral resection of prostate..” The\r\nCanadian Journal of Urology, 24 (4), 8903-8909\r\n\r\nAG Winer, EA Vertosick, M Ghanaat, RB Corradi, S Carlsson, DD\r\nSjoberg, and others (2017). “Prognostic value of lymph node\r\nyield during nephroureterectomy for upper tract urothelial carcinoma.”\r\nUrologic Oncology: Seminars and Original Investigations, 35 (4),\r\n151. e9-151. e15\r\n\r\nY Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja\r\n(2017). “Compositions and methods for active surveillance of prostate\r\ncancer.” US Patent App., 15/143,345\r\n\r\nDP Nguyen, M Kent, A Vilaseca, RB Corradi, N Fossati, DD\r\nSjoberg, and others (2017). “Updated postoperative nomogram\r\nincorporating the number of positive lymph nodes to predict disease\r\nrecurrence following radical prostatectomy.” Prostate Cancer and\r\nProstatic Diseases, 20 (1), 105-109\r\n\r\nLH Rosenberger, R Weber, DD Sjoberg, AJ Vickers, DA\r\nMangino, and others (2017). “Impact of self-reported data on the\r\nacquisition of multi-generational family history and lifestyle factors\r\namong women seen in a high-risk breast screening program: a focus on ….”\r\nBreast cancer research and treatment, 162 (2), 275-282\r\n\r\nJI Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L\r\nEgevad, and others (2016). “A contemporary prostate cancer grading\r\nsystem: a validated alternative to the Gleason score.” European\r\nurology, 69 (3), 428-435\r\n\r\nK Braun, DD Sjoberg, AJ Vickers, H Lilja, AS Bjartell\r\n(2016). “A four-kallikrein panel predicts high-grade cancer on biopsy:\r\nindependent validation in a community cohort.” European urology, 69\r\n(3), 505-511\r\n\r\nM Spaliviero, BY Poon, CA Karlo, GB Guglielmetti, PL Di Paolo,\r\nDD Sjoberg, and others (2016). “An arterial based\r\ncomplexity (ABC) scoring system to assess the morbidity profile of\r\npartial nephrectomy.” European urology, 69 (1), 72-79\r\n\r\nP Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K\r\nTouijer, and others (2016). “The efficacy of multiparametric magnetic\r\nresonance imaging and magnetic resonance imaging targeted biopsy in risk\r\nclassification for patients with prostate cancer on active ….” The\r\nJournal of urology, 196 (2), 374-381\r\n\r\nDP Nguyen, EA Vertosick, RB Corradi, A Vilaseca, NE Benfante, DD\r\nSjoberg, and others (2016). “Histological subtype of renal cell\r\ncarcinoma significantly affects survival in the era of partial\r\nnephrectomy.” Urologic Oncology: Seminars and original\r\ninvestigations, 34 (6), 259. e1-259. e8\r\n\r\nM Imnadze, DD Sjoberg, AJ Vickers (2016). “Adverse\r\npathologic features at radical prostatectomy: effect of preoperative\r\nrisk on oncologic outcomes.” European urology, 69 (1),\r\n143-148\r\n\r\nC Anderson, R Weber, D Patel, W Lowrance, A Mellis, M Cookson,\r\nDD Sjoberg, and others (2016). “A 10-item checklist\r\nimproves reporting of critical procedural elements during transurethral\r\nresection of bladder tumor.” The Journal of urology, 196 (4),\r\n1014-1020\r\n\r\nDJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA\r\nEastham, and others (2016). “Comparative effectiveness of targeted\r\nprostate biopsy using magnetic resonance imaging ultrasound fusion\r\nsoftware and visual targeting: a prospective study.” The Journal of\r\nUrology, 196 (3), 697-702\r\n\r\nCD Jakubowski, EA Vertosick, BR Untch, DD Sjoberg, E\r\nWei, FL Palmer, and others (2016). “Complete metastasectomy for renal\r\ncell carcinoma: comparison of five solid organ sites.” Journal of\r\nsurgical oncology, 114 (3), 375-379\r\n\r\nA Sankin, AL Tin, R Mano, M Chevinsky, C Jakubowski, JP Sfakianos,\r\nDD Sjoberg, and others (2016). “Impact of ureteroscopy\r\nbefore nephroureterectomy for upper tract urothelial carcinoma on\r\noncologic outcomes.” Urology, 94, 148-153\r\n\r\nLV Selby, M Sovel, DD Sjoberg, M McSweeney, D Douglas,\r\nDR Jones, and others (2016). “Preoperative chemoprophylaxis is safe in\r\nmajor oncology operations and effective at preventing venous\r\nthromboembolism.” Journal of the American College of Surgeons, 222\r\n(2), 129-137\r\n\r\nR Mano, EA Vertosick, AA Hakimi, IA Sternberg, DD\r\nSjoberg, M Bernstein, and others (2016). “The effect of\r\ndelaying nephrectomy on oncologic outcomes in patients with renal tumors\r\ngreater than 4 cm.” Urologic Oncology: Seminars and Original\r\nInvestigations, 34 (5), 239. e1-239. e8\r\n\r\nN Fossati, NM Passoni, M Moschini, G Gandaglia, A Larcher, M Freschi,\r\nDD Sjoberg, and others (2016). “Impact of stage\r\nmigration and practice changes on high‐risk prostate cancer: results\r\nfrom patients treated with radical prostatectomy over the last two\r\ndecades.” BJU international, 117 (5), 740-747\r\n\r\nWM Bazzi, AL Tin, DD Sjoberg, M Bernstein, P Russo\r\n(2016). “The prognostic utility of preoperative neutrophil-to-lymphocyte\r\nratio in localized clear cell renal cell carcinoma.” The Canadian\r\njournal of urology, 23 (1), 8151\r\n\r\nA Rönnblom, T Holmström, H Tanghöj, U Karlbom, M Thörn, D Sjöberg\r\n(2016). “Low colectomy rate five years after diagnosis of ulcerative\r\ncolitis. Results from a prospective population-based cohort in Sweden\r\n(ICURE) diagnosed during 2005–2009.” Scandinavian Journal of\r\nGastroenterology, 51 (11), 1339-1344\r\n\r\nNW Liu, JD Wren, E Vertosick, JK Lee, NE Power, NE Benfante, SY Kimm,\r\nDD Sjoberg, and others (2016). “The prognostic impact\r\nof a positive vascular margin on pT3 clear cell renal cell carcinoma.”\r\nThe Journal of urology, 195 (2), 264-269\r\n\r\nA Ronnblom, T Holmstrom, H Tanghoj, U Karlbom, M Thorn, DD\r\nSjoberg (2016). “Low colectomy rate five years after diagnosis\r\nof ulcerative colitis. Results from a prospective population-based\r\ncohort in Sweden (ICURE) diagnosed during 2005-2009.” Scandinavian\r\njournal of gastroenterology, 51 (11), 1339-1344\r\n\r\nP Recabal, M Assel, JE Musser, RJ Caras, DD Sjoberg, JA\r\nColeman, and others (2016). “Erectile function recovery after radical\r\nprostatectomy in men with high risk features.” The Journal of\r\nurology, 196 (2), 507-513\r\n\r\nDJ Lee, P Recabal, DD Sjoberg, A Thong, JK Lee, JA\r\nEastham, and others (2016). “Comparative effectiveness of targeted\r\nprostate biopsy using MRI-US fusion software and visual targeting: a\r\nprospective study.” The Journal of urology, 196 (3),\r\n697\r\n\r\nDP Nguyen, A Vilaseca, EA Vertosick, RB Corradi, KA Touijer, DD\r\nSjoberg, and others (2016). “Histologic subtype impacts\r\ncancer-specific survival in patients with sarcomatoid-variant renal cell\r\ncarcinoma treated surgically.” World journal of urology, 34 (4),\r\n539-544\r\n\r\nB Ehdaie, BY Poon, DD Sjoberg, P Recabal, V Laudone, K\r\nTouijer, and others (2016). “Variation in serum prostate‐specific\r\nantigen levels in men with prostate cancer managed with active\r\nsurveillance.” BJU international, 118 (4), 535-540\r\n\r\nCB Anderson, AL Tin, DD Sjoberg, JP Mulhall, J Sandhu,\r\nK Touijer, and others (2016). “Association between number of prostate\r\nbiopsies and patient‐reported functional outcomes after radical\r\nprostatectomy: implications for active surveillance protocols.” BJU\r\ninternational, 117 (6B), E46-E51\r\n\r\nG Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD\r\nSjoberg, JA Eastham, and others (2016). “Number of metastatic\r\nlymph nodes as determinant of outcome after salvage radical\r\nprostatectomy for radiation-recurrent prostate cancer.” Actas\r\nUrológicas Españolas (English Edition), 40 (7), 434-439\r\n\r\nP Recabal, M Assel, DD Sjoberg, D Lee, VP Laudone, K\r\nTouijer, and others (2016). “The efficacy of multiparametric magnetic\r\nresonance imaging and MRI-targeted biopsy in risk classification for\r\npatients with prostate cancer on active surveillance.” The Journal\r\nof urology, 196 (2), 374\r\n\r\nY Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja\r\n(2016). “Compositions and methods for active surveillance of prostate\r\ncancer.” US Patent App., 15/143,329\r\n\r\nMA Feuerstein, JE Musser, M Kent, M Chevinsky, EK Cha, S Kimm,\r\nDD Sjoberg, and others (2016). “Low yield of\r\nsurveillance imaging after surgery for T1 kidney cancer.” World\r\njournal of urology, 34 (7), 949-953\r\n\r\nA Vilaseca Cabo, D Nguyen, A Tin, R Corradi, A Martin-Malburet,\r\nDD Sjoberg, and others (2016). “433 Long-term\r\noncological outcomes of salvage radical prostatectomy for\r\nradio-recurrent/persistent prostate cancer after radiation therapy.”\r\nEUROPEAN UROLOGY-SUPPLEMENTS-, 15 (3), e433-e433\r\n\r\nG Gugliemetti, R Sukhu, MAC Baenas, J Meeks, DD\r\nSjoberg, JA Eastham, and others (2016). “Número de ganglios\r\nlinfáticos metastásicos como determinante de los resultados de la\r\nprostatectomía radical de rescate en el cáncer de próstata de\r\nrecidivante tras radioterapia.” Actas Urológicas Españolas, 40 (7),\r\n434-439\r\n\r\nD Lin, M Brown, L Newcomb, DD Sjoberg, J Brooks, P\r\nCarroll, A Dash, and others (2016). “PD08-02 evaluating the four\r\nkallikrein panel of the 4kscore for prediction of high-grade prostate\r\ncancer in men in the canary prostate active surveillance study (PASS).”\r\nThe Journal of Urology, 195 (4S), e229-e229\r\n\r\nY Dong, AJ Vickers, DD Sjoberg, PT Scardino, H Lilja\r\n(2016). “Compositions and methods for active surveillance of prostate\r\ncancer.” , \r\n\r\nJ Epstein, MJ Zelefsky, DD Sjoberg, JB Nelson, L\r\nEgevad, and others (2016). “A Contemporary Prostate Cancer Grading\r\nSystem: A Validated Alternative to the Gleason Score (Retraction of Vol\r\n69, Pg 428, 2016).” PATHOLOGY INTERNATIONAL, 66 (10),\r\n600-+\r\n\r\nM Imnadze, DD Sjoberg, J Lee, LC Jenkins, A Vickers, JP\r\nMulhall, B Ehdaie (2016). “050 Improved Recovery of Erectile Function in\r\nYounger Men after Radical Prostatectomy: Does it Justify Immediate\r\nIntervention in Low-Risk Patients?.” The Journal of Sexual Medicine,\r\n13 (5), S24\r\n\r\nD Siemens, H Klotz, A Heidenreich, S Chowdhury, A Villers, B Baron,\r\nDD Sjoberg, and others (2016). “Podium Session 1:\r\nProstate Cancer June 26, 2016 1050–1150.” Canadian Urological\r\nAssociation Journal= Journal de L’association des …, \r\n\r\nBH Bochner, G Dalbagni, DD Sjoberg, J Silberstein, GEK\r\nPaz, SM Donat, and others (2015). “Comparing open radical cystectomy and\r\nrobot-assisted laparoscopic radical cystectomy: a randomized clinical\r\ntrial.” European urology, 67 (6), 1042-1050\r\n\r\nDJ Parekh, S Punnen, DD Sjoberg, SW Asroff, JL Bailen,\r\nJS Cochran, and others (2015). “A multi-institutional prospective trial\r\nin the USA confirms that the 4Kscore accurately identifies men with\r\nhigh-grade prostate cancer.” European urology, 68 (3),\r\n464-470\r\n\r\nRJ Bryant, DD Sjoberg, AJ Vickers, MC Robinson, R\r\nKumar, L Marsden, and others (2015). “Predicting high-grade cancer at\r\nten-core prostate biopsy using four kallikrein markers measured in blood\r\nin the ProtecT study.” JNCI: Journal of the National Cancer\r\nInstitute, 107 (7)\r\n\r\nP Stattin, AJ Vickers, DD Sjoberg, R Johansson, T\r\nGranfors, M Johansson, and others (2015). “Improving the specificity of\r\nscreening for lethal prostate cancer using prostate-specific antigen and\r\na panel of kallikrein markers: a nested case–control study.”\r\nEuropean urology, 68 (2), 207-213\r\n\r\nAJ Vickers, DD Sjoberg (2015). “Guidelines for\r\nreporting of statistics in European Urology.” Eur Urol, 67 (2),\r\n181-187\r\n\r\nLV Selby, EA Vertosick, DD Sjoberg, MA Schattner, YY\r\nJanjigian, and others (2015). “Morbidity after total gastrectomy:\r\nanalysis of 238 patients.” Journal of the American College of\r\nSurgeons, 220 (5), 863-871. e2\r\n\r\nJK Lee, M Assel, AE Thong, DD Sjoberg, JP Mulhall, J\r\nSandhu, and others (2015). “Unexpected long-term improvements in urinary\r\nand erectile function in a large cohort of men with self-reported\r\noutcomes following radical prostatectomy.” European urology, 68 (5),\r\n899-905\r\n\r\nM Spaliviero, BY Poon, O Aras, PL Di Paolo, GB Guglielmetti, DD\r\nSjoberg, and others (2015). “Interobserver variability of\r\nRENAL, PADUA, and centrality index nephrometry score systems.” World\r\njournal of urology, 33 (6), 853-858\r\n\r\nKM Wesa, NH Segal, AM Cronin, DD Sjoberg, GN Jacobs, MI\r\nColeton, and others (2015). “Serum 25-hydroxy vitamin D and survival in\r\nadvanced colorectal cancer: a retrospective analysis.” Nutrition and\r\ncancer, 67 (3), 424-430\r\n\r\nM Chevinsky, M Imnadze, A Sankin, A Winer, R Mano, C Jakubowski,\r\nDD Sjoberg, and others (2015). “Pathological stage T3a\r\nsignificantly increases disease recurrence across all tumor sizes in\r\nrenal cell carcinoma.” The Journal of urology, 194 (2),\r\n310-315\r\n\r\nWM Bazzi, DD Sjoberg, MA Feuerstein, A Maschino, S\r\nVerma, and others (2015). “Long-term survival rates after resection for\r\nlocally advanced kidney cancer: Memorial Sloan Kettering Cancer Center\r\n1989 to 2012 experience.” The Journal of urology, 193 (6),\r\n1911-1917\r\n\r\nR Mano, M Kent, Y Larish, AG Winer, MS Chevinsky, AA Hakimi, DD\r\nSjoberg, and others (2015). “Partial and radical nephrectomy\r\nfor unilateral synchronous multifocal renal cortical tumors.”\r\nUrology, 85 (6), 1404-1410\r\n\r\nCB Anderson, IA Sternberg, G Karen-Paz, PH Kim, DD\r\nSjoberg, HA Vargas, and others (2015). “Age is associated with\r\nupgrading at confirmatory biopsy among men with prostate cancer treated\r\nwith active surveillance.” The Journal of Urology, 194 (6),\r\n1607-1611\r\n\r\nJL Silberstein, SA Poon, DD Sjoberg, AC Maschino, AJ\r\nVickers, A Bernie, and others (2015). “Long‐term oncological outcomes of\r\na phase II trial of neoadjuvant chemohormonal therapy followed by\r\nradical prostatectomy for patients with clinically localised,\r\nhigh‐risk ….” BJU international, 116 (1), 50-56\r\n\r\nTP Ghoneim, DD Sjoberg, W Lowrance, SF Shariat, C\r\nSavage, and others (2015). “Partial nephrectomy for renal tumors in\r\nsolitary kidneys: postoperative renal function dynamics.” World\r\njournal of urology, 33 (12), 2023-2029\r\n\r\nR Mano, E Vertosick, AI Sankin, MS Chevinsky, Y Larish, CD Jakubowski,\r\nDD Sjoberg, and others (2015). “Subcentimeter pulmonary\r\nnodules are not associated with disease progression in patients with\r\nrenal cell carcinoma.” The Journal of urology, 193 (3),\r\n776-782\r\n\r\nWM Bazzi, DD Sjoberg, AAC Grasso, M Bernstein, R Parra,\r\nJA Coleman (2015). “Predicting length of stay after robotic partial\r\nnephrectomy.” International urology and nephrology, 47 (8),\r\n1321-1325\r\n\r\nT Gondo, BY Poon, K Matsumoto, M Bernstein, DD Sjoberg,\r\nJA Eastham (2015). “Clinical role of pathological downgrading after\r\nradical prostatectomy in patients with biopsy confirmed G leason score\r\n3+ 4 prostate cancer.” BJU international, 115 (1),\r\n81-86\r\n\r\nLV Selby, DD Sjoberg, D Cassella, M Sovel, MR Weiser, K\r\nSepkowitz, and others (2015). “Comparing surgical infections in national\r\nsurgical quality improvement project and an institutional database.”\r\nJournal of Surgical Research, 196 (2), 416-420\r\n\r\nN Fossati, A Larcher, GM Gadda, DD Sjoberg, FA\r\nMistretta, P Dell’Oglio, and others (2015). “Minimally invasive partial\r\nnephrectomy versus laparoscopic cryoablation for patients newly\r\ndiagnosed with a single small renal mass.” European Urology Focus, 1\r\n(1), 66-72\r\n\r\nWM Bazzi, LY Chen, BH Cordon, J Mashni, DD Sjoberg, M\r\nBernstein, and others (2015). “Non-neoplastic parenchymal changes in\r\nkidney cancer and post-partial nephrectomy recovery of renal function.”\r\nInternational urology and nephrology, 47 (9), 1499-1502\r\n\r\nJE Musser, MJ Assel, JJ Meeks, DD Sjoberg, AJ Vickers,\r\nJA Coleman, and others (2015). “Ambulatory extended recovery: safely\r\ntransitioning to overnight observation for minimally invasive\r\nprostatectomy.” Urology Practice, 2 (3), 121-125\r\n\r\nN Fossati, DD Sjoberg, U Capitanio, G Gandaglia, A\r\nLarcher, A Nini, and others (2015). “Extended pelvic lymph node\r\ndissection in patients with prostate cancer previously treated with\r\nsurgery for lower urinary tract symptoms.” BJU international, 116\r\n(3), 366-372\r\n\r\nC Eriksson, S Almer, JA Bjork, M Eberhardson, A Eriksson, O Grip,\r\nDD Sjoberg, and others (2015). “Vedolizumab in\r\ninflammatory bowel disease, the first experience from the Swedish IBD\r\nRegistry (SWIBREG).” Gastroenterology, 148 (4),\r\nS871-S871\r\n\r\nM Cesarini, G Collins, A Ronnblom, A Santos, DD\r\nSjoberg, M Parkes, and others (2015). “Predicting the risk of\r\nacute severe colitis (ASC) at diagnosis of Ulcerative Colitis (UC):\r\nexternal validation.” Journal of Crohn’s and Colitis, 9 (suppl\r\n1)\r\n\r\nAJ Vickers, DD Sjoberg (2015). “Decision analysis of\r\ndutasteride use for patients with negative prostate biopsy.”\r\nUrology, 85 (2), 337-342\r\n\r\nS Punnen, S Zappala, J Palou, DD Sjoberg, V Mathur, R\r\nRoberts, V Vincent, and others (2015). “433 Among men with low-grade\r\nprostate cancer on prostate biopsy, the 4Kscore predicts the presence of\r\nmore aggressive prostate cancer.” European urology supplements:\r\nofficial journal of the European Association …, \r\n\r\nA Bondarik, D Sjöberg (2015). “Implementation of UC-EBG structure for 60\r\nGHz gridded parasitic patch stacked microstrip antenna.” , 2015 9th\r\nEuropean Conference on Antennas and Propagation (EuCAP),\r\n1-5\r\n\r\nJL Silberstein, SA Poon, DD Sjoberg (2015).\r\n“Neoadjuvante Chemohormontherapie vor radikaler Prostatektomie?.”\r\nUrologie Scan, 2 (04), 251-251\r\n\r\nBH Bochner, G Dalbagni, DD Sjoberg (2015). “Offen\r\nchirurgische versus roboterassistierte laparoskopische radikale\r\nZystektomie.” Urologie Scan, 2 (04), 247-247\r\n\r\nN Power, C Willie, C Mazzola, T Tailly, E Sonke, S Pardhan, A Tram,\r\nDD Sjoberg, and others (2015). “2015 CUA Abstracts.”\r\nCanadian Urological Association Journal= Journal de L’association\r\ndes …, \r\n\r\nEK Bancroft, EC Page, E Castro, H Lilja, A Vickers, DD\r\nSjoberg, M Assel, and others (2014). “Targeted prostate cancer\r\nscreening in BRCA1 and BRCA2 mutation carriers: results from the initial\r\nscreening round of the IMPACT study.” European urology, 66 (3),\r\n489-499\r\n\r\nKA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA\r\nEastham (2014). “Long-term outcomes of patients with lymph node\r\nmetastasis treated with radical prostatectomy without adjuvant\r\nandrogen-deprivation therapy.” European urology, 65 (1),\r\n20-25\r\n\r\nS Carlsson, M Assel, DD Sjoberg, D Ulmert, J Hugosson,\r\nH Lilja, A Vickers (2014). “Influence of blood prostate specific antigen\r\nlevels at age 60 on benefits and harms of prostate cancer screening:\r\npopulation based cohort study.” Bmj, 348\r\n\r\nAJ Vickers, DD Sjoberg, D Ulmert, E Vertosick, MJ\r\nRoobol, I Thompson, and others (2014). “Empirical estimates of prostate\r\ncancer overdiagnosis by age and prostate-specific antigen.” BMC\r\nmedicine, 12 (1), 1-7\r\n\r\nM Spaliviero, G Dalbagni, BH Bochner, BY Poon, H Huang, DD\r\nSjoberg, and others (2014). “Clinical outcome of patients with\r\nT1 micropapillary urothelial carcinoma of the bladder.” The Journal\r\nof urology, 192 (3), 702-707\r\n\r\nK Braun, Y Ahallal, DD Sjoberg, T Ghoneim, MD Esteban,\r\nJ Mulhall, and others (2014). “Effect of repeated prostate biopsies on\r\nerectile function in men on active surveillance for prostate cancer.”\r\nThe Journal of urology, 191 (3), 744-749\r\n\r\nT Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J\r\nColeman, P Russo (2014). “Impact of a common clinical pathway on length\r\nof hospital stay in patients undergoing open and minimally invasive\r\nkidney surgery.” The Journal of urology, 191 (5),\r\n1225-1230\r\n\r\nT Tarin, A Feifer, S Kimm, L Chen, DD Sjoberg, J\r\nColeman, P Russo (2014). “Impact of a common clinical pathway on length\r\nof hospital stay in patients undergoing open and minimally invasive\r\nkidney surgery.” The Journal of urology, 191 (5),\r\n1225-1230\r\n\r\nJE Musser, M Assel, JW Mashni, DD Sjoberg, P Russo\r\n(2014). “Adult prostate sarcoma: the Memorial Sloan Kettering\r\nexperience.” Urology, 84 (3), 624-628\r\n\r\nPH Kim, R Sukhu, BH Cordon, JP Sfakianos, DD Sjoberg,\r\nAA Hakimi, and others (2014). “Reflex fluorescence in situ hybridization\r\nassay for suspicious urinary cytology in patients with bladder cancer\r\nwith negative surveillance cystoscopy.” BJU international, 114 (3),\r\n354-359\r\n\r\nM Matignon, R Ding, DM Dadhania, FB Mueller, C Hartono, DD\r\nSjoberg, and others (2014). “Urinary cell mRNA profiles and\r\ndifferential diagnosis of acute kidney graft dysfunction.” Journal\r\nof the American Society of Nephrology, 25 (7), 1586-1597\r\n\r\nS Carlsson, A Berglund, DD Sjoberg, A Khatami, J\r\nStranne, S Bergdahl, and others (2014). “Effects of surgeon variability\r\non oncologic and functional outcomes in a population-based setting.”\r\nBMC urology, 14 (1), 1-8\r\n\r\nSK Hong, BY Poon, DD Sjoberg, PT Scardino, JA Eastham\r\n(2014). “Prostate size and adverse pathologic features in men undergoing\r\nradical prostatectomy.” Urology, 84 (1), 153-157\r\n\r\nJE Musser, M Assel, GB Guglielmetti, P Pathak, JL Silberstein,\r\nDD Sjoberg, and others (2014). “Impact of routine use\r\nof surgical drains on incidence of complications with robot-assisted\r\nradical prostatectomy.” Journal of endourology, 28 (11),\r\n1333-1337\r\n\r\nKA Moses, LY Chen, DD Sjoberg, M Bernstein, KA Touijer\r\n(2014). “Black and White men younger than 50 years of age demonstrate\r\nsimilar outcomes after radical prostatectomy.” BMC urology, 14 (1),\r\n1-6\r\n\r\nM Rieken, RS Djajadiningrat, LA Kluth, RL Favaretto, E Xylinas,\r\nDD Sjoberg, and others (2014). “Predictors of\r\ncancer-specific mortality after disease recurrence in patients with\r\nsquamous cell carcinoma of the penis.” European urology, 66 (5),\r\n811-814\r\n\r\nSK Hong, E Vertosick, DD Sjoberg, PT Scardino, JA\r\nEastham (2014). “Insignificant disease among men with intermediate-risk\r\nprostate cancer.” World journal of urology, 32 (6),\r\n1417-1421\r\n\r\nB Ehdaie, DD Sjoberg, PH Dalecki, PT Scardino, JA\r\nEastham, D Amar (2014). “Association of anesthesia technique for radical\r\nprostatectomy with biochemical recurrence: a retrospective cohort\r\nstudy.” Canadian Journal of Anesthesia/Journal canadien\r\nd’anesthésie, 61 (12), 1068-1074\r\n\r\nS Carlsson, M Assel, DD Sjoberg (2014). “L’effet du\r\ndépistage du cancer de la prostate, dépend-il du taux du PSA à l’âge de\r\n60 ans?.” Minerva, 13 (10), 123-124\r\n\r\nSW Fine, J Chang, JB Poon, DD Sjoberg, HA Al-Ahmadie,\r\nYB Chen, and others (2014). “Gleason Score 7 with Tertiary Pattern 5: A\r\nContemporary Analysis.” LABORATORY INVESTIGATION, 94,\r\n227A-228A\r\n\r\nAJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk,\r\nA Gerdtsson, and others (2013). “Strategy for detection of prostate\r\ncancer based on relation between prostate specific antigen at age 40-55\r\nand long term risk of metastasis: case-control study.” Bmj,\r\n346\r\n\r\nM Rink, DJ Lee, M Kent, E Xylinas, HM Fritsche, M Babjuk, A Brisuda,\r\nDD Sjoberg, and others (2013). “Predictors of\r\ncancer‐specific mortality after disease recurrence following radical\r\ncystectomy.” BJU international, 111 (3b), E30-E36\r\n\r\nBR Cassileth, KJ Van Zee, KS Yeung, MI Coleton, S Cohen, YH Chan,\r\nDD Sjoberg, and others (2013). “Acupuncture in the\r\ntreatment of upper‐limb lymphedema: Results of a pilot study.”\r\nCancer, 119 (13), 2455-2461\r\n\r\nA Christensson, C Savage, DD Sjoberg, AM Cronin, M\r\nFrank O’Brien, and others (2013). “Association of cancer with moderately\r\nimpaired renal function at baseline in a large, representative,\r\npopulation‐based cohort followed for up to 30 years.” International\r\nJournal of Cancer, 133 (6), 1452-1458\r\n\r\nV Margulis, SF Shariat, Y Rapoport, M Rink, DD Sjoberg,\r\nNM Tannir, and others (2013). “Development of accurate models for\r\nindividualized prediction of survival after cytoreductive nephrectomy\r\nfor metastatic renal cell carcinoma.” European urology, 63 (5),\r\n947-952\r\n\r\nG Deng, Y Chan, DD Sjoberg, A Vickers, KS Yeung, M\r\nKris, D Straus, and others (2013). “Acupuncture for the treatment of\r\npost-chemotherapy chronic fatigue: a randomized, blinded,\r\nsham-controlled trial.” Supportive Care in Cancer, 21 (6),\r\n1735-1741\r\n\r\nSV Carlsson, LJ Tafe, DC Chade, DD Sjoberg, N Passoni,\r\nSF Shariat, and others (2013). “Pathological features of lymph node\r\nmetastasis for predicting biochemical recurrence after radical\r\nprostatectomy for prostate cancer.” The Journal of urology, 189 (4),\r\n1314-1319\r\n\r\nG Deng, WD Wong, J Guillem, Y Chan, T Affuso, KS Yeung, M Coleton,\r\nDD Sjoberg, and others (2013). “A phase II, randomized,\r\ncontrolled trial of acupuncture for reduction of postcolectomy ileus.”\r\nAnnals of surgical oncology, 20 (4), 1164-1169\r\n\r\nJA Forsberg, DD Sjoberg, QR Chen, A Vickers, JH Healey\r\n(2013). “Treating metastatic disease: which survival model is best\r\nsuited for the clinic?.” Clinical Orthopaedics and Related\r\nResearch®, 471 (3), 843-850\r\n\r\nAA Hakimi, L Chen, PH Kim, DD Sjoberg, L Glickman, MR\r\nWalker, P Russo (2013). “The impact of metformin use on recurrence and\r\ncancer-specific survival in clinically localized high-risk renal cell\r\ncarcinoma.” Canadian Urological Association Journal, 7 (11-12),\r\nE687\r\n\r\nAJ Vickers, DD Sjoberg, DP Ankerst, CM Tangen, PJ\r\nGoodman, and others (2013). “The Prostate Cancer Prevention Trial risk\r\ncalculator and the relationship between prostate‐specific antigen and\r\nbiopsy outcome.” Cancer, 119 (16), 3007-3011\r\n\r\nSV Carlsson, MT Peltola, DD Sjoberg, FH Schröder, J\r\nHugosson, and others (2013). “Can one blood draw replace transrectal\r\nultrasonography‐estimated prostate volume to predict prostate cancer\r\nrisk?.” BJU international, 112 (5), 602-609\r\n\r\nJL Silberstein, PC Sprenkle, D Su, NE Power, TV Tarin, P Ezell,\r\nDD Sjoberg, and others (2013). “Neutrophil\r\ngelatinase-associated lipocalin (NGAL) levels in response to unilateral\r\nrenal ischaemia in a novel pilot two-kidney porcine model.” BJU\r\ninternational, 112 (4), 517\r\n\r\nKA Touijer, CR Mazzola, DD Sjoberg, PT Scardino, JA\r\nEastham (2013). “Reply to Michael Froehner, Rainer Koch, and Manfred P.\r\nWirth’s letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola,\r\nDaniel D. Sjoberg, Peter T. Scardino, James A ….” European Urology,\r\n65 (2), e25-6\r\n\r\nW Breitbart, S Poppito, B Rosenfeld, AJ Vickers, Y Li, J Abbey, M Olden,\r\nDD Sjoberg, and others (2012). “Pilot randomized\r\ncontrolled trial of individual meaning-centered psychotherapy for\r\npatients with advanced cancer..” Journal of clinical oncology:\r\nofficial journal of the American Society of …, \r\n\r\nTV Tarin, NE Power, B Ehdaie, JP Sfakianos, JL Silberstein, CJ Savage,\r\nDD Sjoberg, and others (2012). “Lymph node–positive\r\nbladder cancer treated with radical cystectomy and lymphadenectomy:\r\neffect of the level of node positivity.” European urology, 61 (5),\r\n1025-1030\r\n\r\nM Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas,\r\nRK Lee, J Hansen, and others (2012). “Risk of cancer-specific mortality\r\nfollowing recurrence after radical nephroureterectomy.” Annals of\r\nsurgical oncology, 19 (13), 4337-4344\r\n\r\nM Gustafsson, I Vakili, SEB Keskin, DD Sjoberg, C\r\nLarsson (2012). “Optical theorem and forward scattering sum rule for\r\nperiodic structures.” IEEE transactions on antennas and propagation,\r\n60 (8), 3818-3826\r\n\r\nA Sankin, JP Sfakianos, J Schiff, DD Sjoberg, JA\r\nColeman (2012). “Assessing renal function after partial nephrectomy\r\nusing renal nuclear scintigraphy and estimated glomerular filtration\r\nrate.” Urology, 80 (2), 343-346\r\n\r\nAJ Vickers, DD Sjoberg, E Basch, F Sculli, M Shouery, V\r\nLaudone, and others (2012). “How do you know if you are any good? A\r\nsurgeon performance feedback system for the outcomes of radical\r\nprostatectomy.” European urology, 61 (2), 284\r\n\r\nY Ahallal, K Braun, DD Sjoberg, T Ghoneim, M Esteban, J\r\nMulhall, and others (2012). “Impact des biopsies répétées sur la\r\nfonction érectile chez les patients sous surveillance active pour cancer\r\nde la prostate.” Progrès en Urologie, 22 (13), 810\r\n\r\nM Rink, DD Sjoberg, E Comploj, V Margulis, E Xylinas, R\r\nLee, J Hansen, and others (2012). “Time to Disease Recurrence is a\r\nPredictor of Cancer-Specific Mortality After Radical\r\nNephroureterectomy.” UROLOGY, 80 (3), S332-S332\r\n\r\nHF Hochberg-Garrett, DM Hoelscher, SV Sharma, DD\r\nSjoberg (2009). “The Skip to Breakfast Project: Development,\r\nImplementation, and Evaluation of an Intervention to Increase Healthful\r\nBreakfast Consumption among Fifth Grade Students and Their ….”\r\nJournal of the American Dietetic Association, 9 (109), A81\r\n\r\n\r\n\r\n\r\n",
      "last_modified": "2022-11-04T15:28:40-04:00"
    },
    {
      "path": "software.html",
      "author": [],
      "contents": "\r\ngtsummary\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe {gtsummary} package provides an elegant and flexible way to create publication-ready analytic and summary tables using the R programming language.\r\nThe {gtsummary} package summarizes data sets, regression models, and more, using sensible defaults with highly customizable capabilities.\r\nBy leveraging {broom}, {gt}, and {labelled} packages, {gtsummary} creates beautifully formatted, ready-to-share summary and result tables in a single line of R code!\r\n\r\nSummarize data frames or\r\ntibbles\r\neasily in R. Perfect for presenting descriptive statistics,\r\ncomparing group demographics (e.g creating a Table 1 for\r\nmedical journals), and more. Automatically detects continuous,\r\ncategorical, and dichotomous variables in your data set, calculates\r\nappropriate descriptive statistics, and also includes amount of\r\nmissingness in each variable.\r\nSummarize regression\r\nmodels\r\nin R and include reference rows for categorical variables. Common\r\nregression models, such as logistic regression and Cox proportional\r\nhazards regression, are automatically identified and the tables are\r\npre-filled with appropriate column headers (i.e. Odds Ratio and\r\nHazard Ratio).\r\nCustomize gtsummary\r\ntables\r\nusing a growing list of formatting/styling functions.\r\nBold\r\nlabels,\r\nitalicize\r\nlevels, add\r\np-value\r\nto summary tables,\r\nstyle\r\nthe statistics however you choose,\r\nmerge\r\nor\r\nstack\r\ntables to present results side by side… there are so many\r\npossibilities to create the table of your dreams!\r\nReport statistics\r\ninline\r\nfrom summary tables and regression summary tables in R markdown.\r\nMake your reports completely reproducible!\r\nInstallation Code: install.packages(\"gtsummary\")\r\nMore information at http://www.danieldsjoberg.com/gtsummary/\r\nDecision Curve Analysis\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguages R, Stata, SAS\r\nDecision-analytic techniques allow assessment of clinical outcomes but often require collection of additional information may be cumbersome to apply to models that yield a continuous result.\r\nDecision curve analysis is a method for evaluating and comparing prediction models that incorporates clinical consequences, requires only the data set on which the models are tested, and can be applied to models that have either continuous or dichotomous results.\r\nDetailed tutorial and installation instructions at https://www.danieldsjoberg.com/dca-tutorial/dca-tutorial-r.html\r\nR package website: http://www.danieldsjoberg.com/dcurves/\r\n\r\nVickers AJ, Elkin EB. “Decision curve analysis: a novel method for evaluating prediction models.” Medical Decision Making. 2006 Nov-Dec;26(6):565-74.\r\nVickers AJ, Cronin AM, Elkin EB, Gonen M. “Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.” BMC Medical Informatics and Decision Making. 2008 Nov 26;8(1):53.\r\nggsurvfit\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe {ggsurvfit} package eases the creation of time-to-event (aka survival) endpoint figures with ggplot.\r\nThe concise and modular code creates images that are ready for publication or sharing.\r\nEach of the functions that add to or modify the existing ggplot are written as proper ggplot geoms or stat methods, allowing the functions from this package to be combined with any functions or customization from ggplot and other ggplot extensions.\r\n\r\nInstallation Code: install.packages(\"ggsurvfit\")\r\nMore information at http://www.danieldsjoberg.com/ggsurvfit/\r\nstarter\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nGet started with new projects by dropping a skeleton of a new project into a new or existing directory, initialise git repositories, and create reproducible environments with the ‘renv’ package.\r\nThe package allows for dynamically named files, folders, file content, as well as the functionality to drop individual template files into existing projects.\r\n\r\nInstallation Code: install.packages(\"starter\")\r\nMore information at http://www.danieldsjoberg.com/starter/\r\nrstudio.prefs\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nAs of RStudio v1.3, the preferences in the Global Options dialog (and a number of other preferences that aren’t) are now saved in simple, plain-text JSON files.\r\nThis package provides an interface for working with these RStudio JSON preference files to easily make modifications without using the point-and-click option menus.\r\nThis is particularly helpful when working on teams to ensure a unified experience across machines and utilizing settings for best practices.\r\n\r\nInstallation Code: install.packages(\"rstudio.prefs\")\r\nMore information at http://www.danieldsjoberg.com/rstudio.prefs/\r\ngtreg\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe {gtreg} package creates tabular data summaries appropriate for regulatory submissions.\r\nThe package builds the tables using {gtsummary}.\r\n\r\nInstallation Code: install.packages(\"gtreg\")\r\nMore information at https://shannonpileggi.github.io/gtreg/\r\nbroom.helpers\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe {broom.helpers} package provides suite of functions to work with regression model broom::tidy() tibbles.\r\nThe suite includes functions to group regression model terms by variable, insert reference and header rows for categorical variables, add variable labels, and more.\r\n{broom.helpers} is used, in particular, by gtsummary::tbl_regression() for producing nice formatted tables of model coefficients and by GGally::ggcoef_model() for plotting model coefficients.\r\n\r\nInstallation Code: install.packages(\"broom.helpers\")\r\nMore information at https://larmarange.github.io/broom.helpers/\r\nvisR\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nEnables fit-for-purpose, reusable clinical and medical research focused visualizations and tables with sensible defaults and based on sound graphical principles.\r\n\r\nInstallation Code: install.packages(\"visR\")\r\nMore information at https://openpharma.github.io/visR/\r\ntidycmprsk\r\nLanguage R\r\nThe {tidycmprsk} package provides an intuitive interface for working with the competing risk endpoints.\r\nThe package wraps the {cmprsk} package, and exports functions for univariate cumulative incidence estimates with cuminc() and competing risk regression with crr().\r\nThe package also includes broom-style tidiers: tidy(), augment(), and glance().\r\nInstallation Code: install.packages(\"tidycmprsk\")\r\nMore information at https://mskcc-epi-bio.github.io/tidycmprsk/\r\nbstfun\r\nLanguage R\r\nA miscellaneous collection of functions to used by members of the Biostatistics Department at MSKCC.\r\nFunctions in the {bstfun} package do not fall within the well-defined packages with more narrow scope used by the department.\r\nInstallation Code: devtools::install_github(\"ddsjoberg/bstfun\")\r\nMore information at http://www.danieldsjoberg.com/bstfun/\r\nContributions\r\ngtExtras\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe goal of {gtExtras} is to provide some additional helper functions to assist in creating beautiful tables with {gt.}\r\nThe functions are generally wrappers around boilerplate or adding capabilities that are currently not yet built into {gt}. The {gt} package is amazing, make sure to go read the official documentation.\r\n\r\nInstallation Code: remotes::install_github(\"jthomasmock/gtExtras\")\r\nMore information at https://jthomasmock.github.io/gtExtras/\r\nbroom\r\n\r\n\r\n\r\n\r\n\r\n\r\nLanguage R\r\nThe {broom} package summarizes key information about models in tidy tibbles.\r\n{broom} provides three verbs to make it convenient to interact with model objects: tidy(), glance(), and augment().\r\n\r\nInstallation Code: install.packages(\"broom\")\r\nMore information at https://broom.tidymodels.org/\r\n\r\n\r\n\r\n",
      "last_modified": "2022-11-04T15:26:42-04:00"
    }
  ],
  "collections": []
}
